1-2 of 2
Stephen DeWall
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Expression of Myeloma Cell and Soluble B-Cell Maturation Antigen (BCMA) in Relapsed and Refractory Multiple Myeloma Patients Treated with GSK2857916 in BMA117159

E.J. Dettman, PhD BS, Fabio Rigat, PhD, Josh Albert, BS, Ruth Barnard, PhD, Mary Birchler, BS, Yan Deghenhardt, PhD, Stephen DeWall, PhD, Boyenoh Gaye, MS, Zangdong He, PhD, Veronica Liu, MS, Joanna Opalinska
Journal: Blood
Blood (2018) 132 (Supplement 1): 1977.
https://doi.org/10.1182/blood-2018-99-115200
Published: 2018
Journal Articles

First in Human Study with GSK2857916, an Antibody Drug Conjugated to Microtubule-Disrupting Agent Directed Against B-Cell Maturation Antigen (BCMA) in Patients with Relapsed/Refractory Multiple Myeloma (MM): Results from Study BMA117159 Part 1 Dose Escalation

Adam D. Cohen, MD, Rakesh Popat, Suzanne Trudel, MD, Paul G Richardson, MD, Ed N. Libby, III, MD, Nikoletta Lendvai, MDPhD, Larry D. Anderson, Jr., MD PhD, Heather J. Sutherland, MD PhD, Stephen DeWall, Catherine E Ellis, Zangdong He, Jolly Mazumdar, Catherine Wang, Joanna B. Opalinska, MD PhD, Peter M. Voorhees, MD
Journal: Blood
Blood (2016) 128 (22): 1148.
https://doi.org/10.1182/blood.V128.22.1148.1148
Published: 2016